跳至主要内容
临床试验/IRCT20120506009651N3
IRCT20120506009651N3已完成3 期

Efficacy of Aniseed powder formulation (Aniseed Safoof) to improve gastrointestinal symptoms in COVID-19 patients

Shiraz University of Medical Sciences0 个研究点目标入组 225 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
225

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Patients from 18 years old to 70 years old with a diagnosis of Coronavirus based on clinical and laboratory symptoms; hospitalization, home quarantine and outpatients
  • Diarrhea, anorexia, nausea or vomiting and abdominal pain within 24-48 hr

排除标准

  • Pregnant or nursing females
  • Organic disorders with survival time of less than 3 days
  • Significant allergic reactions to the herbal drug

研究者

相似试验